V. Antipas

A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration.

N. Uzunoglu, D. Dionysiou, G. Stamatakos, 2004, Physics in medicine and biology.

Simulating chemotherapeutic schemes in the individualized treatment context: The paradigm of glioblastoma multiforme treated by temozolomide in vivo

Nikolaos K. Uzunoglu, Georgios S. Stamatakos, Vassilis P. Antipas, 2006, Comput. Biol. Medicine.

A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide

Nikolaos K. Uzunoglu, Georgios S. Stamatakos, Vassilis P. Antipas, 2006, IEEE Transactions on Biomedical Engineering.

Glioblastoma multiforme treated by the chemotherapeutic agent temozolomide in vivo: a 4D simulation model of the tumor response

N. Uzunoglu, G. Stamatakos, V. Antipas, 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.

A Patient-specific in vivo Tumor and Normal Tissue Model for Prediction of the Response to Radiotherapy

Georgios Stamatakos, V P Antipas, N K Ozunoglu, 2007, Methods of Information in Medicine.

The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants.

C. Armpilia, B. Jones, R. Dale, 2003, International journal of radiation oncology, biology, physics.

A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density.

V P Antipas, R G Dale, G S Stamatakos, 2006, The British journal of radiology.

A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd

R. Dale, I. Coles, V. Antipas, 2001, Physics in medicine and biology.